Rose L, Owusu‐Brackett N, Moore S, Oppong B. Loss of TSC1 in secondary angiosarcoma of the breast.
Clin Case Rep 2023;
11:e7539. [PMID:
37484752 PMCID:
PMC10357003 DOI:
10.1002/ccr3.7539]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Revised: 04/26/2023] [Accepted: 06/02/2023] [Indexed: 07/25/2023] Open
Abstract
Key Clinical Message
Post-radiation angiosarcoma of the breast is a rare complication associated with a poor prognosis. This case reports the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma and illustrates the utility of evaluating these markers to identify potential therapeutic targets.
Abstract
Post-radiation angiosarcoma of the breast is rare and associated with a poor prognosis. This case presents the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma. Evaluation of these markers can aid in identifying potential therapeutic targets.
Collapse